Hers vs Sprout Health: FDA Brand vs Compounded GLP-1 Options
Quick verdict: For brand-name, FDA-approved GLP-1s and a personalized care team choose Hers; for faster onboarding and a lower initial price choose Sprout Health. This Hers vs Sprout Health comparison highlights price, FDA approval status, onboarding speed, membership requirements, and outcome claims.
Price and membership: upfront and ongoing costs compared
Hers lists Wegovy from $149/mo and injectable options from $199/mo, but notes an active Hers Weight Loss Membership is required with a first month fee of $39 and auto-renew at $149/month thereafter. Sprout Health advertises a $50 off first month offer that brings the initial cost to $199 and states ongoing pricing rises to $249/month.
FDA-approved brand-name medication versus compounded formulations
One of the clearest differences in this Hers vs Sprout Health pairing is whether medication is a brand-name FDA-approved finished product or a compounded product. Hers explicitly offers FDA-approved Wegovy, described as a brand-name semaglutide product and not compounded. Sprout Health prescribes compounded semaglutide and its captured content notes compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Choose Hers for FDA-approved Wegovy
Onboarding speed and care model
Hers emphasizes a personalized care team with ongoing dose check-ins, indicating more hands-on follow up. Sprout Health promotes a lightning-quick approval process and a fast, no-friction entry designed for patients who want minimal onboarding time. The comparison shows Hers focuses on ongoing clinician-managed dose checks while Sprout Health focuses on rapid prescription review and delivery.
Outcome framing and claims
Sprout Health frames outcomes around a 10 to 26 percent body weight reduction over 12 months and presents this as expected ranges based on GLP-1 clinical literature, while noting individual results vary and it does not offer a formal outcome guarantee. Hers highlights availability of FDA-approved options and captured landing page examples showing weight changes in sample timelines, but the supplied evidence does not present a formal guaranteed outcome from Hers.
Availability, regulatory notes, and suitability
Hers notes not all treatments are available in all 50 states and that prescriptions are subject to clinician review; it also emphasizes that Ozempic and Mounjaro are FDA-approved for type 2 diabetes and available only to patients who meet clinical eligibility criteria. Sprout Health’s captured content also states treatment is available only when a licensed clinician determines it is medically appropriate and repeats the regulatory caution that compounded medications are not FDA-approved. Both providers operate on a prescription after clinician review and direct-pay models in the captured evidence.
Comparison table: quick side-by-side
| Criteria | Hers | Sprout Health |
|---|---|---|
| Starting price | Wegovy from $149/mo; injectable from $199/mo | $50 off first month, bringing it to $199; $249/mo ongoing |
| Medication type | FDA-approved Wegovy brand-name semaglutide, not compounded | Compounded semaglutide; compounded products not FDA-reviewed |
| Membership requirement | Active Hers Weight Loss Membership required; first month $39, then auto-renew at $149/mo | Direct-pay model; $50 first month offer noted |
| Onboarding speed | Personalized care team with ongoing dose check-ins | Lightning-quick approval and fast entry |
| Outcome framing | Highlights FDA-approved options; sample weight-change content captured | Frames 10 to 26 percent body weight loss in 12 months; no formal guarantee |
How to pick between Hers and Sprout Health
Decide based on your priorities. If access to an FDA-approved brand-name GLP-1 and a personalized care team with ongoing dose check-ins are most important, the captured evidence supports Hers as the choice. If you prioritize fast approval and a lower initial monthly charge with an introductory discount and accept compounded medication, the captured evidence supports Sprout Health.
Start Sprout Health enrollment
Final thoughts on Hers vs Sprout Health
In this Hers vs Sprout Health comparison, the most distinctive supported differences are price structure and membership, FDA-approved brand-name medication versus compounded formulations, onboarding speed versus a more hands-on care model, and how outcomes are framed. Both require clinician review for prescriptions and both operate on direct-pay approaches in the captured evidence.
Compare Hers treatment options
Choose Provider guidance
Choose Hers if you want FDA-approved Wegovy brand-name semaglutide, a personalized care team with ongoing dose check-ins, and are prepared for a membership requirement. Choose Sprout Health if you want faster approval, a lower initial month cost with $50 off, and are willing to use compounded semaglutide with higher ongoing pricing after the discount.